Anti-HER2 therapy in metastatic breast cancer: many choices and future directions.

Wynn, Carrie S; Tang, Shou-Ching

Wynn, Carrie S; Tang, Shou-Ching.

Afiliación

Wynn CS; Cancer Center and Research Institute, University of Mississippi Medical Center, Guyton Research Building, G-651-07, 2500 North State Street, Jackson, MS, 39216, USA.
Tang SC; Cancer Center and Research Institute, University of Mississippi Medical Center, Guyton Research Building, G-651-07, 2500 North State Street, Jackson, MS, 39216, USA. Stang2@umc.edu.

Cancer Metastasis Rev ; 41(1): 193-209, 2022 03.

Article en En | MEDLINE | ID: mdl-35142964

Asunto(s)

Neoplasias Encefálicas; Neoplasias de la Mama; Neoplasias de la Mama/patología; Resistencia a Antineoplásicos; Femenino; Humanos; Fosfatidilinositol 3-Quinasas; Receptor ErbB-2/metabolismo; Trastuzumab/uso terapéutico

Palabras clave

Anti-HER2 therapy; Drug resistance; HER2 + metastatic breast cancer; New drugs; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de la Mama Idioma: En Revista: Cancer Metastasis Rev Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google